These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 3367936)

  • 1. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors.
    Edwards CQ; Griffen LM; Goldgar D; Drummond C; Skolnick MH; Kushner JP
    N Engl J Med; 1988 May; 318(21):1355-62. PubMed ID: 3367936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic efficacy of screening tests for hereditary hemochromatosis.
    Borwein S; Ghent CN; Valberg LS
    Can Med Assoc J; 1984 Oct; 131(8):895-901. PubMed ID: 6593112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for hemochromatosis in children of homozygotes: prevalence and cost-effectiveness.
    Adams PC; Kertesz AE; Valberg LS
    Hepatology; 1995 Dec; 22(6):1720-7. PubMed ID: 7489980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of idiopathic hemochromatosis in Italy: study of 1301 blood donors.
    Velati C; Piperno A; Fargion S; Colombo S; Fiorelli G
    Haematologica; 1990; 75(4):309-12. PubMed ID: 2276675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary hemochromatosis. Phenotypic expression of the disease.
    Cartwright GE; Edwards CQ; Kravitz K; Skolnick M; Amos DB; Johnson A; Buskjaer L
    N Engl J Med; 1979 Jul; 301(4):175-9. PubMed ID: 449974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis.
    Bulaj ZJ; Griffen LM; Jorde LB; Edwards CQ; Kushner JP
    N Engl J Med; 1996 Dec; 335(24):1799-805. PubMed ID: 8943161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between genotype, assessed by HLA typing, and phenotypic expression of iron status markers in families of 29 probands with hereditary haemochromatosis.
    Milman N; Fenger K; Graudal NA; Nielsen LS
    Dan Med Bull; 1994 Jun; 41(3):366-70. PubMed ID: 7924465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and phenotypic expression of hemochromatosis in Canadians.
    Borwein ST; Ghent CN; Flanagan PR; Chamberlain MJ; Valberg LS
    Clin Invest Med; 1983; 6(3):171-9. PubMed ID: 6652983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests.
    Bassett ML; Halliday JW; Ferris RA; Powell LW
    Gastroenterology; 1984 Sep; 87(3):628-33. PubMed ID: 6745616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of establishing appropriate local reference values for the screening of hemochromatosis: a study of three different control populations and 136 hemochromatosis family members. Hemochromatosis Clinical and Research Group.
    Porto G; Vicente C; Fraga J; da Silva BM; de Sousa M
    J Lab Clin Med; 1992 Mar; 119(3):295-305. PubMed ID: 1541878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for hemochromatosis in asymptomatic subjects with or without a family history.
    Powell LW; Dixon JL; Ramm GA; Purdie DM; Lincoln DJ; Anderson GJ; Subramaniam VN; Hewett DG; Searle JW; Fletcher LM; Crawford DH; Rodgers H; Allen KJ; Cavanaugh JA; Bassett ML
    Arch Intern Med; 2006 Feb; 166(3):294-301. PubMed ID: 16476869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease-related conditions in relatives of patients with hemochromatosis.
    Bulaj ZJ; Ajioka RS; Phillips JD; LaSalle BA; Jorde LB; Griffen LM; Edwards CQ; Kushner JP
    N Engl J Med; 2000 Nov; 343(21):1529-35. PubMed ID: 11087882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic screening for HFE hemochromatosis in 6,020 Danish men: penetrance of C282Y, H63D, and S65C variants.
    Pedersen P; Milman N
    Ann Hematol; 2009 Aug; 88(8):775-84. PubMed ID: 19159930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA determinants in idiopathic haemochromatosis.
    Milman N; Graudal N; Nielsen LS; Sørensen SA
    Dan Med Bull; 1985 Oct; 32(5):262-4. PubMed ID: 4053696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for hemochromatosis: phenotype versus genotype.
    Edwards CQ; Griffen LM; Ajioka RS; Kushner JP
    Semin Hematol; 1998 Jan; 35(1):72-6. PubMed ID: 9460810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of silent liver fibrosis in hemochromatosis C282Y homozygotes with normal transaminase levels.
    Beaton M; Adams PC
    Clin Gastroenterol Hepatol; 2008 Jun; 6(6):713-4. PubMed ID: 18550006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older.
    Baer DM; Simons JL; Staples RL; Rumore GJ; Morton CJ
    Am J Med; 1995 May; 98(5):464-8. PubMed ID: 7733125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for hereditary hemochromatosis in prospective blood donors.
    Benn HP; Nielsen P; Fischer R; Schwarz D; Engelhardt R; Darda C; Dittmer R; Knödler B; Gabbe EE; Kühnl P
    Beitr Infusionsther Transfusionsmed; 1994; 32():314-6. PubMed ID: 9422115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased urinary excretion of 8-iso-prostaglandin F2alpha in patients with HFE-related hemochromatosis: a case-control study.
    Kom GD; Schwedhelm E; Nielsen P; Böger RH
    Free Radic Biol Med; 2006 Apr; 40(7):1194-200. PubMed ID: 16545687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histocompatibility antigens as markers of abnormal iron metabolism in idiopathic hemochromatosis.
    Lloyd DA; Adams P; Sinclair NR; Stiller CR; Valberg LS
    Can Med Assoc J; 1978 Nov; 119(9):1051-6. PubMed ID: 84705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.